• 11464 Citations
  • 61 h-Index
1985 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where David R Corey is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 2 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

  • Progress towards drug discovery for Friedreich's Ataxia: Identifying synthetic oligonucleotides that more potently activate expression of human frataxin protein

    Shen, X., Wong, J., Prakash, T. P., Rigo, F., Li, Y., Napierala, M. & Corey, D. R., Jan 1 2020, (Accepted/In press) In : Bioorganic and Medicinal Chemistry. 115472.

    Research output: Contribution to journalArticle

  • The 10th Oligonucleotide Therapy Approved: Golodirsen for Duchenne Muscular Dystrophy

    Aartsma-Rus, A. & Corey, D. R., Apr 2020, In : Nucleic Acid Therapeutics. 30, 2, p. 67-70 4 p.

    Research output: Contribution to journalReview article

    Open Access

    CHAPTER 2: Mechanisms of Antisense Oligonucleotides

    Liu, Z. & Corey, D. R., Jan 1 2019, Therapies for Retinal Degeneration: Targeting Common Processes. Agrawal, S. & Gait, M. J. (eds.). 68 ed. Royal Society of Chemistry, p. 22-31 10 p. (RSC Drug Discovery Series; vol. 2019-January, no. 68).

    Research output: Chapter in Book/Report/Conference proceedingChapter

  • 1 Scopus citations

    Duplex RNAs and ss-siRNAs Block RNA Foci Associated with Fuchs' Endothelial Corneal Dystrophy

    Hu, J., Shen, X., Rigo, F., Prakash, T. P., Mootha, V. V. & Corey, D. R., Apr 2019, In : Nucleic Acid Therapeutics. 29, 2, p. 73-81 9 p.

    Research output: Contribution to journalArticle

  • 1 Scopus citations